is wegovy a glp 1 agonist Novo's becomes first GLP-1 drug approved for MASH is wegovy a glp 1
Description
& Wu, G
Hence, the rising prevalence of obesity is likely to affect market growth by increasing the demand for GLP-1 receptor agonists
Wegovy is specifically approved for chronic weight management, while Ozempic is primarily used for managing type 2 diabetes (though it may be prescribed off-label for weight loss)
But studies aren't confined to the here and now
By increasing GLP-1 production or stimulating its release, this approach can complement existing therapies, such as GLP-1RAs and DPP-4 inhibitors, offering additional benefits while potentially reducing side effects
